S E Doe
Overview
Explore the profile of S E Doe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kay J, Kromwel L, Doe S, Denyer M
Immunology
. 1991 Apr;
72(4):544-9.
PMID: 1709916
The immunosuppressive macrolide rapamycin shows marked structural similarity to FK-506, and like FK-506 inhibits the activation of cultured T and B lymphocytes at concentrations as low as 10(-10) M. However,...
2.
Doe S, Benzie C, Kay J
Biochem Soc Trans
. 1990 Jun;
18(3):451-2.
PMID: 1695581
No abstract available.
3.
Kay J, Moore A, Doe S, Benzie C, Schonbrunner R, Schmid F, et al.
Transplant Proc
. 1990 Feb;
22(1):96-9.
PMID: 1689914
No abstract available.
4.
Kay J, Doe S, Benzie C
Cell Immunol
. 1989 Nov;
124(1):175-81.
PMID: 2478301
The novel immunosuppressive drug FK-506 inhibits the induction of lymphocyte proliferation in vitro by mitogenic combinations of phorbol esters and calcium ionophores. Early events inducible by phorbol esters alone are...
5.
Kay J, Benzie C, Goodier M, Wick C, Doe S
Immunology
. 1989 Aug;
67(4):473-7.
PMID: 2475433
Nanamolar concentrations of the immunosuppressive drug FK-506 inhibit the induction of T-lymphocyte proliferation by the lectins concanavalin A (Con A) and phytohaemagglutinin (PHA). Activation by Con A is more sensitive...